Covid-19 vaccine: Bangladesh to receive 1.09 crore shots under COVAX by May
Bangladesh will receive 10,908,000 shots of Oxford-AstraZeneca's Covid-19 vaccine by May, under the global arrangement called COVAX.
The Coalition for Epidemic Preparedness Innovations (CEPI), the Vaccine Alliance (GAVI) and the World Health Organization (WHO), as co-leads of the COVAX initiative for equitable global access to Covid-19 vaccines, alongside key delivery partner UNICEF, have published COVAX's first round of allocations.
According to the list, Bangladesh is the fourth country to receive the vaccine.
Following the publication of an interim distribution forecast, and based on current knowledge of supply availability, the first round of allocation provides information regarding provision of doses of the Oxford-AstraZeneca vaccine to COVAX facility participants through May 2021.
The first round of allocation outlines delivery of doses of the Oxford-AstraZeneca vaccine -- manufactured by Serum Institute of India -- to facility participants.
This list will be updated by the end of the week to provide tentative timelines for the supply of doses, split into Feb-March and April-May.
Deliveries for this round of allocations have already begun, with India, Ghana and Cote d'Ivoire receiving doses of the Oxford-AstraZeneca vaccine. Both Ghana and Cote d'Ivoire began vaccination campaigns utilising these doses on Monday. Further deliveries are underway for this week. As readiness criteria are fulfilled and doses become available, deliveries will continue on a rolling basis over the coming months.
In addition to the first round of allocations, an exceptional distribution of 1.2 million doses of the Pfizer-BioNTech vaccines, anticipated for delivery in Q1 2021, was announced in early February.
Further allocation rounds in the COVAX portfolio will be announced in due course.
Comments